Jennifer Sugg

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

Jan Bolinder, Östen Ljunggren, Joel Kullberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 860 citations

Medicine, Endocrinology, Pharmacology +17

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

Jan Bolinder, Östen Ljunggren, Lars Johansson et al. · Diabetes Obesity and Metabolism · 2013 · 479 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

Cora N. Sternberg, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2020 · 422 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years

John Wilding, Vincent Woo, Katja Rohwedder et al. · Diabetes Obesity and Metabolism · 2013 · 295 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17